Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/39271
Tipo
ArtículoDerechos de autor
Acceso abierto
Objetivos de Desarrollo Sostenible
03 Saúde e Bem-EstarColecciones
- INI - Artigos de Periódicos [3486]
Metadatos
Mostrar el registro completo del ítem
NEW OPPORTUNITIES IN TUBERCULOSIS PREVENTION: IMPLICATIONS FOR PEOPLE LIVING WITH HIV
HV care continuum
Differentiated care
Public health
Co‐infection
Treatment
Autor
Afiliación
HIV Co-Infections and Co-Morbidities. The International AIDS Society. Geneva, Switzerland.
Southern Africa Medical Unit. Médecins Sans Frontières. Cape Town, South Africa.
HIV Department. World Health Organization. Geneva, Switzerland.
Aurum Institute. Parktown, South Africa / School of Public Health. University of Witwatersrand. Johannesburg, South Africa / Advancing Care and Treatment for TB/HIV. South African Medical Research Council. Parktown, South Africa.
Department of Tuberculosis. International Union Against Tuberculosis and Lung Disease. Geneva, Switzerland.
Department of Medicine and Director of the "Alexander Von Humboldt" Institute of Tropical Medicine and Infectious Diseases. Peruvian University Cayetano Heredia. Lima, Peru.
Global Network of People living with HIV (GNP+). Cape Town, South Africa.
Stop TB Partnership. Geneva, Switzerland.
Bureau for Global Health. Infectious Diseases. TB Division. USAID. Washington, DC, USA.
Department of Medicine. University of Malaya. Kuala Lumpur, Malaysia.
Infectious Diseases Department. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
University of Nebraska Medical Center. Omaha, NE, USA.
Southern Africa Medical Unit. Médecins Sans Frontières. Cape Town, South Africa.
HIV Department. World Health Organization. Geneva, Switzerland.
Aurum Institute. Parktown, South Africa / School of Public Health. University of Witwatersrand. Johannesburg, South Africa / Advancing Care and Treatment for TB/HIV. South African Medical Research Council. Parktown, South Africa.
Department of Tuberculosis. International Union Against Tuberculosis and Lung Disease. Geneva, Switzerland.
Department of Medicine and Director of the "Alexander Von Humboldt" Institute of Tropical Medicine and Infectious Diseases. Peruvian University Cayetano Heredia. Lima, Peru.
Global Network of People living with HIV (GNP+). Cape Town, South Africa.
Stop TB Partnership. Geneva, Switzerland.
Bureau for Global Health. Infectious Diseases. TB Division. USAID. Washington, DC, USA.
Department of Medicine. University of Malaya. Kuala Lumpur, Malaysia.
Infectious Diseases Department. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
University of Nebraska Medical Center. Omaha, NE, USA.
Resumen en ingles
Tuberculosis (TB) is a leading cause of mortality among people living with HIV (PLHIV). An invigorated global END TB Strategy seeks to increase efforts in scaling up TB preventive therapy (TPT) as a central intervention for HIV programmes in an effort to contribute to a 90% reduction in TB incidence and 95% reduction in mortality by 2035. TPT in PLHIV should be part of a comprehensive approach to reduce TB transmission, illness and death that also includes TB active case-finding and prompt, effective and timely initiation of anti-TB therapy among PLHIV. However, the use and implementation of preventive strategies has remained deplorably inadequate and today TB prevention among PLHIV has become an urgent priority globally.
Palabras clave en ingles
TBHV care continuum
Differentiated care
Public health
Co‐infection
Treatment
Compartir